DeDora Capital Inc. purchased a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 1,221 shares of the financial services provider's stock, valued at approximately $324,000.
Other institutional investors and hedge funds have also modified their holdings of the company. SeaCrest Wealth Management LLC increased its position in CME Group by 3.0% during the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock valued at $366,000 after purchasing an additional 40 shares during the period. New Age Alpha Advisors LLC boosted its stake in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. OneAscent Financial Services LLC boosted its stake in CME Group by 4.0% in the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after purchasing an additional 43 shares in the last quarter. Ballentine Partners LLC boosted its stake in CME Group by 0.8% in the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after purchasing an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC boosted its stake in CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after purchasing an additional 47 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have recently commented on CME shares. Citigroup upped their price target on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Piper Sandler increased their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $261.80.
Read Our Latest Stock Analysis on CME Group
Insider Buying and Selling at CME Group
In related news, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the sale, the director owned 3,108 shares of the company's stock, valued at $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the completion of the acquisition, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have sold 13,400 shares of company stock valued at $3,680,610. Insiders own 0.30% of the company's stock.
CME Group Stock Down 0.1%
NASDAQ:CME traded down $0.36 during mid-day trading on Tuesday, reaching $274.64. The company's stock had a trading volume of 2,682,922 shares, compared to its average volume of 2,188,891. CME Group Inc. has a 1 year low of $193.25 and a 1 year high of $290.79. The stock has a fifty day moving average of $275.89 and a 200-day moving average of $261.04. The firm has a market capitalization of $98.97 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 4.82 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm earned $2.50 earnings per share. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. Equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. CME Group's payout ratio is 50.30%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.